FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Member
|
Apparently there is a new drug that is a derivative of Gilenya. They are starting phase 3 trials for up to 5 years to treat SPMS. Just thought I'd post in case anyone is interested.
http://www.nationalmssociety.org/new....aspx?nid=7954
__________________
On Tysabri and love it. . |
|||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
Biotie's tozadenant (SYN115) meets primary and multiple secondary endpoints in phase | Parkinson's Disease | |||
drug for secondary progressive MS | Multiple Sclerosis | |||
CLINICAL TRIAL...Phase III Trial with Pimavanserin in Patients with PD Psychosis | Parkinson's Disease Clinical Trials | |||
CLINICAL TRIAL...Risk Factors for Progressive Supranuclear Palsy (PSP) | Parkinson's Disease Clinical Trials |